Latest filing published 04 Aug 2020 for ESSA Pharma Inc., €2.3M.
Insider track record
Clarus Lifesciences III, L.P.: trading record in brief
All filings by Clarus Lifesciences III, L.P. on record concern ESSA Pharma Inc. Over a trading history stretching from 9 January 2018 to 31 July 2020, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 4 August 2020 came the latest disclosure, a transaction for €2.3M in ESSA Pharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 18 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Clarus Lifesciences III, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,704,493 shares@ CA$2.0031.8% of flowCommon SharesTSXSEDI:3583523
- 200,000 shares@ CA$6.0010.4% of flowCommon SharesTSXSEDI:3583532
- 31,702,651 sharesCommon SharesTSXSEDI:3175626
- 31,250,000 shares@ CA$0.20100.0% of flowCommon SharesTSXSEDI:3131438
4 of 4 declarations